Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,301,261 papers from all fields of science
Search
Sign In
Create Free Account
CRKL gene
Known as:
V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like Gene
, ONCOGENE CRKL
, V-CRK AVIAN SARCOMA VIRUS CT10 ONCOGENE HOMOLOG-LIKE
Expand
This gene plays a role in cell communication and signal transduction.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CRKL protein
Signal Transduction
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Identification of somatic copy number variations in plasma cell free DNA correlating with intrinsic resistances to EGFR targeted therapy in T790M negative non-small cell lung cancer
Lucheng Zhu
,
Jiafeng Liang
,
+4 authors
Shirong Zhang
Journal of Thoracic Disease
2020
Corpus ID: 214675619
Background About 20–30% EGFR-mutant non-small lung cancer show intrinsic resistance to EGFR targeted therapies. Compared to T790M…
Expand
2018
2018
Quantitative proteomics reveals that miR‐222 inhibits erythroid differentiation by targeting BLVRA and CRKL
Li Jiang
,
Xing Wang
,
Yong Wang
,
Xiaoyan Chen
Cell Biochemistry and Function
2018
Corpus ID: 3687635
miR‐222 plays an important role in erythroid differentiation, but the potential targets of miR‐222 in the regulation of erythroid…
Expand
2017
2017
[Phenotypic and genotypic analysis of a fetus carrying an intermediate 22q11.2 deletion encompassing the CRKL gene].
Shaobin Lin
,
Xiaohe Zheng
,
H. Gu
,
Mingzhen Li
Zhonghua yi xue yi chuan xue za zhi = Zhonghua…
2017
Corpus ID: 24198901
OBJECTIVE To delineate the phenotypic characteristics of 22q11.2 deletion syndrome and the role of CRKL gene in the pathogenesis…
Expand
Review
2016
Review
2016
Delineation of a recognizable phenotype for the recurrent LCR22‐C to D/E atypical 22q11.2 deletion
Amaya Bengoa-Alonso
,
Mercè Artigas-López
,
M. Moreno-Igoa
,
Claudio Cattalli
,
B. Hernández-Charro
,
M. Ramos-Arroyo
American Journal of Medical Genetics. Part A
2016
Corpus ID: 39550716
The 22q11.2 deletion syndrome is typically caused by haploinsufficiency of a 3 Mb region that extends from LCR22‐A until LCR22‐D…
Expand
2014
2014
CrkL regulates SDF-1-induced breast cancer biology through balancing Erk1/2 and PI3K/Akt pathways
Xin Lian
,
Y. Jiao
,
+11 authors
Qingyuan Zhang
Medical Oncology
2014
Corpus ID: 22210936
Abstract The adapter protein CrkL is required for regulating the malignant potential of human cancers. However, the regulatory…
Expand
2014
2014
CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation.
K. Suda
,
H. Mizuuchi
,
+8 authors
T. Mitsudomi
Lung Cancer
2014
Corpus ID: 23482737
2014
2014
A Mouse Splice-Site Mutant and Individuals with Atypical Chromosome 22q11.2 Deletions Demonstrate the Crucial Role for Crkl in Craniofacial and Pharyngeal Development
K. Miller
,
T. Tan
,
+9 authors
P. Farlie
Molecular Syndromology
2014
Corpus ID: 207716351
The 22q11.2 deletion syndrome (22q11DS) is thought to be a contiguous gene syndrome caused by haploinsufficiency for a variable…
Expand
2012
2012
An atypical 0.8 Mb inherited duplication of 22q11.2 associated with psychomotor impairment.
C. Pébrel-Richard
,
S. Kémény
,
+6 authors
P. Vago
European Journal of Medical Genetics
2012
Corpus ID: 207645416
2010
2010
Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene.
M. Kostrzewska-Poczekaj
,
M. Giefing
,
+6 authors
K. Szyfter
Cancer Biomarkers
2010
Corpus ID: 24047388
Thirteen laryngeal squamous cell carcinoma cell lines were recently studied by array comparative genomic hybridization (array-CGH…
Expand
2008
2008
Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells.
Shao-hua Shen
,
L. Gu
,
Peigang Liu
,
X. Ye
,
Wei-Shan Chang
,
Ben-shang Li
Chinese Medical Journal
2008
Corpus ID: 24791069
BACKGROUND Multidrug resistance to chemotherapeutic agents is an important clinical problem during the treatment of leukemia. The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE